Cited by 61Mitochondrial Function and PathologyParkinson's Disease Mechanisms and TreatmentsMetabolism and Genetic Disorders

Autosomal dominant progressive external ophthalmoplegia: Distribution of multiple mitochondrial DNA deletions

Moslemi, Ali-Reza, Melberg, Atle, Holme, Elisabeth, Oldfors, Anders·1999·Neurology

Abstract

OBJECTIVE: To relate signs and symptoms to morphologic changes and presence of multiple mitochondrial DNA (mtDNA) deletions in a patient with autosomal dominant progressive external ophthalmoplegia (adPEO) and mitochondrial myopathy. BACKGROUND: An etiologic association between the somatic multiple mtDNA deletions in adPEO and clinical manifestations other than the myopathy has so far not been demonstrated. METHODS: The authors investigated a patient with adPEO and multiorgan system manifestations including levodopa-responsive parkinsonism. She died at age 61 years of pancreatic carcinoma. Autopsy tissue specimens were investigated for morphologic alterations and occurrence of mtDNA deletions by Southern blot and long-extension PCR analyses. RESULTS: The patient had carcinoma of the pancreas with metastases to liver, lymph nodes, and bone marrow. The brain revealed slight gliosis of the gray and white matter and degeneration of the substantia nigra. The myocardium showed focal areas with loss and atrophy of myocytes and fibrosis. Analysis of mtDNA revealed multiple deletions in different regions of the brain, skeletal muscle, and myocardium. Twenty-five different mtDNA deletions were identified. Most of these were flanked by large direct-sequence repeats. Six identical deletions were found in muscle and brain. CONCLUSIONS: These findings indicate that somatic multiple mtDNA deletions are associated with degenerative tissue changes and clinical manifestations in adPEO.

Integrity signals

Registry

Crossref · 10.1212/wnl.53.1.79

Cites

47 of 47 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Moslemi, A.-R., Melberg, A., Holme, E., & Oldfors, A.
Affiliations
Uppsala University Hospital (SE)
Venue
Neurology
Published
1999-07
Volume
53
Issue
1
Pages
79-79
ISSN
  • 0028-3878 (ISSN-L)
  • 1526-632X
OpenAlex
W2015149058
Cited by
61
References
46
Citations by year
2021: 1 · 2020: 2 · 2018: 2 · 2017: 1 · 2016: 2 · 2015: 3 · 2014: 1 · 2013: 4 · 2012: 2
FWCI
1.71
Type
journal article
Language
en
Open access
closed
Locations
  • Neurology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
  • Health Sciences › Medicine › Neurology › Parkinson's Disease Mechanisms and Treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
Keywords
mitochondrial DNA deletions, mitochondrial myopathy, levodopa-responsive parkinsonism, pancreatic cancer, substantia nigra degeneration, myocardial fibrosis, gliosis, somatic mtDNA mutations
MeSH terms
Antiparkinson Agents, Brain, Cerebral Cortex, DNA, Mitochondrial, Female, Genes, Dominant, Humans, Levodopa, Middle Aged, Parkinson Disease, Repetitive Sequences, Nucleic Acid, Ophthalmoplegia, Chronic Progressive External, Sequence Deletion, Muscle, Skeletal

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review